|
RHOQ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.341500E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.318700E-03 |
| Normal-vs-Stage2 |
2.935000E-01 |
| Normal-vs-Stage3 |
2.933700E-02 |
| Normal-vs-Stage4 |
2.482200E-01 |
| Stage1-vs-Stage2 |
5.614600E-01 |
| Stage1-vs-Stage3 |
8.206800E-01 |
| Stage1-vs-Stage4 |
3.704200E-01 |
| Stage2-vs-Stage3 |
6.758200E-01 |
| Stage2-vs-Stage4 |
9.308200E-01 |
| Stage3-vs-Stage4 |
5.297800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.598100E-03 |
| Normal-vs-AfricanAmerican |
7.554800E-01 |
| Normal-vs-Asian |
2.090800E-01 |
| Caucasian-vs-AfricanAmerican |
1.417560E-01 |
| Caucasian-vs-Asian |
5.755400E-01 |
| AfricanAmerican-vs-Asian |
5.329600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.741600E-02 |
| Normal-vs-Female |
8.936300E-03 |
| Male-vs-Female |
6.781400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.148310E-02 |
| Normal-vs-Age(41-60Yrs) |
5.178500E-03 |
| Normal-vs-Age(61-80Yrs) |
3.249200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.167000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.983800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.927020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.429200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.204410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.027600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.616200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.020000E-01 |
| Classical-VS-Follicular |
4.367500E-02 |
| Classical-VS-Other |
7.183000E-01 |
| Classical-VS-Normal |
6.883900E-03 |
| Tall-VS-Follicular |
5.017400E-01 |
| Tall-VS-Other |
3.446400E-01 |
| Tall-VS-Normal |
2.841200E-01 |
| Follicular-VS-Other |
7.404000E-02 |
| Follicular-VS-Normal |
7.779200E-01 |
| Other-VS-Normal |
8.642000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.268340E-02 |
| Normal-vs-N1 |
4.120500E-03 |
| N0-vs-N1 |
3.418600E-01 |
|
|
